INTENSITY THERAPEUTICS, INC. Other Current Assets
INTENSITY THERAPEUTICS, INC. (INTS) had Other Current Assets of $6.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-03-14
- 2023-12-31: Other Assets, Current $6.00K.
- 2023-09-30: Other Assets, Current $14.37K.
- 2023-06-30: Other Assets, Current $159.46K.
- 2022-12-31: Other Assets, Current $76.00K; Other Assets, Current as first filed $138.46K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2023-12-31 | $6.00K 10-K · filed 2024-03-14 | |
| 2023-09-30 | $14.37K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $159.46K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $76.00K 10-K · filed 2024-03-14 | $138.46K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |